Hot Avulsion Versus Argon 13/NTA/122 Approve Dr Ravinder Ogra CMDHB Research Office Intervention Plasma Coagulation Quetiapine 1 x 200 mg bioequivalence study 13/NTA/124 Approve Dr Noelyn Hung Intervention conducted under fed conditions Metoprolol 1 x 200 mg Zenith Technology Corporation bioequivalence study 13/NTA/125 Approve Dr Noelyn Hung Limited, Zenith Technology Intervention conducted under fasting Corporation Limited conditions A comparison of BI 695500 and rituximab metabolism and processing in the body Dr William 13/NTA/126 Approve Auckland Clinical Studies Intervention in follicular lymphoma Patton patients with low tumour burden Tibolone 1 x 2.5 mg pilot bioequivalence study 13/NTA/127 Approve Dr Noelyn Hung Intervention conducted under fasting conditions Canterbury Urology Research Mr Nicholas Buchan, Mr Trust, Cardinal Points Research Associate Professor Anthony Nixon, Mr Patrick 13/NTA/13 Approve SPARTAN Ltd,Michael Holmes, Peter Gilling, Intervention Peter Gilling Bary, Doctor Patrick Roundhay Medical ,Waitemata Meffan, Mr Tony Beaven DHB Vemurafenib with Acenocoumarol in patients Auckland District Health 13/NTA/14 Approve with BRAFV600 mutation Dr Chris Wynne Intervention Board,Chris Taylor, CCST positive metastatic malignancy. 13/NTA/143 Approve CheckMate067 Dr Mike McCrystal Auckland District Health Board Intervention Dr Walaa Saweirs,Clinical Dr Michael Roberts, Chief Medical A/Prof John Collins,Dr 13/NTA/144 Approve the CKD-FIX trial Dr de Zoysa Officer,Jan Adams, Intervention Kannaiyan Rabindranath,Dr COO,Waitemata DHB Suetonia Palmer Associate Professor 13/NTA/145 Approve PQ Bypass Dr Andrew Hill Auckland District Health Board Intervention Andrew Holden
13/NTA/122 Approve Hot Avulsion Versus Argon Plasma Coagulation Dr Ravinder Ogra CMDHB Research Office Intervention 13/NTA/124 Approve Quetiapine 1 x 200 mg bioequivalence study conducted under fed conditions Dr Noelyn Hung Intervention 13/NTA/125 Approve Metoprolol 1 x 200 mg bioequivalence study conducted under fasting conditions Dr Noelyn Hung Zenith Technology Corporation Limited, Zenith Technology Corporation Limited Intervention 13/NTA/126 Approve A comparison of BI 695500 and rituximab metabolism and processing in the body in follicular lymphoma patients with low tumour burden Dr William Patton Auckland Clinical Studies Intervention 13/NTA/127 Approve Tibolone 1 x 2.5 mg pilot bioequivalence study conducted under fasting conditions Dr Noelyn Hung Intervention 13/NTA/13 Approve SPARTAN Associate Professor Peter Gilling Mr Nicholas Buchan, Mr Anthony Nixon, Mr Patrick Bary, Doctor Patrick Meffan, Mr Tony Beaven Canterbury Urology Research Trust, Cardinal Points Research Ltd,Michael Holmes, Peter Gilling, Roundhay Medical ,Waitemata DHB Intervention 13/NTA/14 Approve Vemurafenib with Acenocoumarol in patients with BRAFV600 mutation positive metastatic malignancy. Dr Chris Wynne Auckland District Health Board,Chris Taylor, CCST Intervention 13/NTA/143 Approve CheckMate067 Dr Mike McCrystal Auckland District Health Board Intervention 13/NTA/144 Approve the CKD-FIX trial Dr de Zoysa Dr Walaa Saweirs,Clinical A/Prof John Collins,Dr Kannaiyan Rabindranath,Dr Suetonia Palmer Dr Michael Roberts, Chief Medical Officer,Jan Adams, COO,Waitemata DHB Intervention 13/NTA/145 Approve PQ Bypass Associate Professor Andrew Holden Dr Andrew Hill Auckland District Health Board Intervention